Omega Healthcare Investors (OHI) Tops Q2 EPS by 9c, Beats on Revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Omega Reports Second Quarter 2024 Results and Recent Developments
August 1, 2024 4:15 PM EDTCompleted $648 Million in New Investments Year-to-Date
Increased Full Year Adjusted FFO Guidance
HUNT VALLEY, Md.--(BUSINESS WIRE)-- Omega Healthcare Investors, Inc. (NYSE: OHI) (the Company or Omega) announced today its results for the quarter ended June 30, 2024.
SECOND QUARTER 2024 AND RECENT HIGHLIGHTS
Net income for the quarter of $117 million, or $0.45 per common share, compared to $62 million, or $0.25 per common share, for Q2 2023. Nareit Funds From Operations (Nareit FFO) for the quarter of $189 million, or $0.72 per common share, on 262 million... More
